Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000964504 | SCV001111720 | benign | not provided | 2024-01-26 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000964504 | SCV002097447 | uncertain significance | not provided | 2024-07-11 | criteria provided, single submitter | clinical testing | Identified as a germline alteration in individuals with polycythemia vera or secondary erythrocytosis with or without the acquired V617F variant (PMID: 27647865, 35304527); Identified in samples from diffuse large B-cell tumors, BCR-ABL1 negative and JAK2V617F negative chronic myeloproliferative neoplasms, and head and neck squamous cell carcinomas; however, one study showed no difference in distribution of this variant in patients versus controls, and patient germline samples were not tested (PMID: 22762550, 20417861, 23670291, 33792220); Functional studies indicate that the L393V variant does not seem to synergize in augmenting signaling of the acquired V617F variant (PMID: 27647865); In silico analysis indicates that this missense variant does not alter protein structure/function; This variant is associated with the following publications: (PMID: 23670291, 33792220, 20417861, 31676277, 34426522, 27647865, 22762550, 34958119, 35304527, 37834019, 37762110) |
Ce |
RCV000964504 | SCV004161823 | benign | not provided | 2024-08-01 | criteria provided, single submitter | clinical testing | JAK2: BS1, BS2 |
ARUP Laboratories, |
RCV000964504 | SCV004563833 | uncertain significance | not provided | 2023-09-18 | criteria provided, single submitter | clinical testing | |
Mayo Clinic Laboratories, |
RCV000964504 | SCV005409578 | uncertain significance | not provided | 2024-07-11 | criteria provided, single submitter | clinical testing | BS1, BP4 |
ITMI | RCV000121252 | SCV000085423 | not provided | not specified | 2013-09-19 | no assertion provided | reference population |